Conley Chee - Sep 27, 2021 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role: Chief Commercial Officer
Signature: /s/ Conley Chee
Stock symbol: SYRS
Transactions as of: Sep 27, 2021
Transactions value $: $0
Form type: 3
Date filed: 9/28/2021, 04:21 PM
Next filing: Feb 17, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney